Anticlue

Impac purchases Impath Cancer Registry

Impac has aquired Impath's pathology information management and cancer registry information system businesses for 22 million in cash and liabilities.

Impac will add the Impath Cancer Registry Data to its National Oncology database.

According to the Dow Jones News Wires, Impac's President and Chief Executive Joe Jachinowski, said he expects the acquisition will be slightly dilutive to earnings in 2004 and will add to earnings starting in 2005.

For more information:
Impac's Company Site
Impath's Company Site